LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nantes to Host Biotech Conference in September

By Biotechdaily staff writers
Posted on 15 Aug 2003
The seventh annual European Biotech Crossroads will be held September 25-26, 2003, in Nantes, France. Important figures in the world of biotechnology, including more than 100 leading international experts, will share their insights and experiences in a series of scientific seminars. Attendees can compile their own menu of talks and conferences from the three main tracks of Crossroads: science, business, and careers. In addition, there will be a trade show and a business-partnering convention bringing together investors, startups, and patent attorneys.

In planning the program, the organizers have focused on addressing the hot issues affecting biotechnology (nanotechnology, new diagnostics and analysis tools, clinical trials) as well as tackling topics that have become more traditional (gene therapy, genomics and proteomics, vaccines). The 2002 Biotech Crossroads, held in Lille, attracted 3,208 delegates, 308 exhibitors at the trade show, and 180 participants in the business-partnering convention.

"This conference program demonstrates our commitment to make the European Biotech Crossroads a must for biotech people in Europe,” said Jean-Francois Balducci, chairman of the organizing committee. Further details are available on the conference website.





Related Links:
European Biotech Crossroads

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Aspiration System
VACUSAFE
New
Automated Urinalysis Solution
UN-9000
New
Steam Sterilizer
Hi Vac II Line

Latest BioResearch News

Study Identifies Protein Changes Driving Immunotherapy Resistance in Multiple Myeloma
15 Aug 2003  |   BioResearch

Genetic Analysis Identifies BRCA-Linked Risks Across Multiple Cancers
15 Aug 2003  |   BioResearch

Study Identifies Hidden B-Cell Mutations in Autoimmune Disease
15 Aug 2003  |   BioResearch